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Cardiac Mitochondrial Adaptations Induced by Elevated Lipid Exposure 
Cynthia Rocha 
Apolipoprotein E (ApoE) is necessary for normal lipid metabolism. A deficiency of this protein 
impedes plasma clearance of both triglycerides and cholesterol. These lipids are consequently 
broken down through alternate pathways, thus resulting in atypical cellular function. Cardiac 
mitochondria play a significant role in cellular respiration specifically, considering the extent of 
oxygen consumption that is required by the heart muscle. Their capacity to utilize oxygen and 
produce energy may be affected by the buildup of cholesterol and triglycerides, due to a 
deficiency in ApoE. This study will investigate the influence of ApoE deficiency on energy 
metabolism in young and older female mice. Whether or not any of these effects are exacerbated 
by further supplementation of lipids through diet will also be evaluated in male mice. Cardiac 
mitochondrial oxygen consumption, mitochondrial oxidative phosphorylation (OXPHOS) 
capacity and protein expression in cardiomyocytes will help in examining these influences. Our 
findings have the potential to provide important information regarding lipid shunting into non-
oxidative pathways, which can ultimately disrupt normal cellular function leading to damaging 
effects of the heart. 
Keywords: Apolipoprotein E, mitochondria, cardiac, oxidative capacity, bioenergetics, 
metabolism 
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Cardiovascular disease (CVD) is and has been the primary cause of death in the United 
States since 1918 [American Heart Association, 2005]. It is well established that CVD is also a 
leading universal public health concern as it lies at the root of serious illness, disability and of 
course death. Central to this condition is chronic inflammation whereby oxidized lipoproteins are 
deposited on the vascular walls [Ballinger et al., 2002]. Lipoproteins including Apolipoprotein E 
(ApoE) for example, are soluble molecules that enable the transport of lipids in the plasma. 
ApoE in particular, is a multifunctional lipoprotein, as it is an important component in the 
structure of low-density lipoproteins (LDL) and very low-density lipoproteins (VLDL) [Mahley, 
1988]. It also participates in the uptake of triglyceride-rich lipoproteins (TRL) by the liver and 
has, as such, an ability to suppress the development of atherosclerosis [Raffai, 2012; Lahoz et al., 
2001]. ApoEs role in atherosclerotic regression takes effect regardless of controlled cholesterol 
levels in the blood [Raffai et al., 2005]. Furthermore, ApoE even at suboptimal levels can 
manage the progression of atherosclerosis despite a confirmed case of hypercholesterolemia 
[Raffai et al., 2005]. The genetically engineered ApoE deficient (ApoE-/-) mouse, established 20 
years ago and still commonly used, spontaneously develops atherogenic lesions and 
hypercholesterolemia similar to humans [Plump et al., 1992; Piedrahita et al., 2000]. 
Hypercholesterolemia, a significant risk factor associated with CVD, contributes to high 
levels of oxidative stress in the vascular environment, thus contributing to endothelial 
dysfunction and atherogenesis [Harrison et al., 2011; Torzewski et al., 2007]. Accumulation of 
oxidative stress causes altered metabolism, elevated reactive oxygen species [ROS] production 
and subsequent mitochondrial damage over time. These factors induce pro-inflammatory 
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pathways and other key steps in the pathogenesis of CVD [Harrison et al., 2011]. Furthermore, 
the development of a fatty acid (FA) pool due to ApoE deficiency creates a lipotoxic state 
whereby oxidative stress is enhanced in the mitochondria, possibly inducing apoptosis of both 
adipose and nonadipose cells, as seen in various experimental models using different species 
[Nguyen et al., 2007; de Vries et al., 1997; Van der Vusse et al., 1992].  
Mitochondrial Roles 
Mitochondria may not take up much cellular space yet their exponential significance is 
often underestimated. They are vital to cellular life as well as its end so, it should come as no 
surprise that more and more diseases can be linked at least in some way to mitochondrial 
dysfunction, especially in regards to pathologies of the heart [Duchen, 2004]. Overall, the 
alteration of mitochondrial capacity can result in major or minor disability and also death. For 
example, neurodegenerative diseases (e.g. Parkinson’s), age-related diseases, diabetes and multi-
organ failure in sepsis share a pathophysiological relation to some mitochondrial abnormality. 
The pure fact that we need such a thing as oxygen to survive and experience such bodily 
processes as digestion and absorption is to satiate the demands of the mitochondria, and to 
provide them with enough fuel to carry out all of their important roles [Duchen, 2004]. In fact, 
98% of all inhaled oxygen is used by the mitochondria alone [Duchen, 2004]. Therefore, their 
optimal functioning is critical to the heart as well as the central nervous system and all the other 
systems of the body where they are located. 
Mitochondria are an important source of ROS and when damaged (i.e. by FA 
accumulation) exhibit decreased oxidative based energy and thus less fuel for cells [Elahi et al., 
2009]. In addition, approximately 1-2% of oxygen consumed by the mitochondria is 
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incompletely reduced to water leading to ROS production; under altered physiological 
circumstances this could be damaging for the heart as it consumes a great amount of oxygen and 
is also an important source of ROS [Turrens, 1997]. This is also a fundamental consequence 
since mitochondria are organelles in which energy or adenosine triphosphate (ATP) production 
and cellular respiration occur [Stanley et al., 2005; Saks, 2006]. Furthermore, the maintenance of 
ATP drives all cellular processes in the body especially the heart that, is crucial for a prominent 
workload organ such as the heart because of its high-energy demands [Goldberg et al., 2012; 
Giordano, 2005; Barth et al., 1992; Bers, 2001; Huss & Kelly, 2005].  
Figure 1: Schematic representation of the mitochondrial oxidative phosphorylation system.                            
[Gouspillou et al., 2011]
The capacity of the mitochondria relies heavily on substrate availability, specifically 
lipids and carbohydrates. Their metabolism is based on the utilization of substrates through β-
oxidation and the Kreb’s cycle or through oxidative phosphorylation (OXPHOS) in general. 
OXPHOS is the form of aerobic metabolism whereby carbohydrates, lipids and proteins form 
CO2 and H2O intermediates to ultimately yield ATP. It begins with the electron entry at either 
complex I or II [Irwin et al., 2013]. β-oxidation specifically, produces acetyl-CoA from FAs that 
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enter the Kreb’s cycle to be used by the electron transport system (ETS) for electron transporters, 
reduced nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2), 
in order to generate ATP [Lopaschuk et al., 1994; Fillmore  & Lopaschuk, 2013]. A schematic of 
the ETS is illustrated in Figure 1. The proton motive-force or rather a proton gradient created by 
the passage of electrons along the inner mitochondrial membrane assists the production of ATP 
[Duchen, 2004]. Therefore, the ability of the Kreb’s cycle to extract electrons and generate H+
from citrate to generate NADH and H+ and FADH2 for subsequent passage to the ETS, is its 
most imperative function [Jeukendrup & Gleeson, 1969]. Mitochondrial bioenergetics is further 
summarized schematically in Figure 2.  
The Kreb’s cycle is the main common aerobic metabolic pathway involving 
carbohydrates, lipids and proteins [Akram, 2013]. Acetyl-CoA oxidation by this cycle is 
responsible for two thirds of the sum of ATP production and oxygen consumption [Baldwin & 
Krebs, 1981]. However, a by-product of mitochondrial respiration is ROS that, in high
concentrations risks damaging cell membranes and DNA including mitochondrial DNA 
(mtDNA) [Duchen, 2004]. Nuclear DNA and mtDNA both encode the enzymes critical to 
mitochondrial function [Huss & Kelly, 2005]; mtDNA differs from typical DNA making it 
highly susceptible to oxidative stress and damaging effects from ROS [Sheeran & Pepe, 2006]. 
The leak of electrons to oxygen occurring between mitochondrial complex II and III but not 
directly from complex II, may contribute the most to mitochondrial ROS production, a result 
mirroring a simultaneous increase in mitochondrial potential [Duchen, 2004]. ROS generation 
can actually increase further if respiration is inhibited after these complexes [2004]. 
Figure 2: OXPHOS in carbohydrate and FA metabolism. 
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[Fillmore & Lopaschuk, 2013]
The ETS may therefore be thought of as one of the mitochondria’s most valuable assets. 
Complex I (the first enzyme) is the largest of the 5 complexes in the respiratory system and vital 
to energy production in the cell. It has the ability to extract energy from NADH resulting from 
lipid and carbohydrate oxidation of which, is then trapped across the mitochondrial inner 
membrane (potential difference).  Electrons pass from complex I to III via coenzyme Q10 
(coQ10) meanwhile complex I ships protons from the matrix into the intermembrane space 
contributing to the proton gradient [Irwin et al., 2013]. Complex II oxidizes FADH2 after which, 
electrons via coQ10 are once again transferred over to complex III, another point of entry for 
electrons along with complex I [Irwin et al., 2013; Dudkina et al., 2008]. Complex III undergoes 
a redox reaction involving two enzymes while exporting more protons into the intermembrane 
space. Complex IV is the final electron acceptor and proton pump and reduces oxygen to a water 
















































energy can then fuel ATP synthesis when complex V undergoes a conformational change while 
exposed to the electrochemical potential and the proton gradient along with the temporary new 
structure of this complex, is used to convert ADP to ATP by transporting protons back into the 
matrix [Schultz & Chan, 2001; Irwin et al., 2013].  
Impact of mitochondrial function on cardiac metabolism  
FAs and glucose are oxidized in the mitochondria and contribute the most to cardiac ATP 
production [Stanley & Chandler, 2002; Taegtmeyer, 1994]. However, FAs are the preferred 
substrate (70% of total ATP) making its appropriate uptake from the plasma important for 
cardiac viability [Bing et al., 1954; Shipp et al., 1961; Wisnecki et al., 1987]. Lipids have 
furthermore, been found to be necessary for the pure beating of heart cells [Nutrition Reviews, 
1966]. Under normal physiological conditions, the rate of uptake of FAs into muscle fibers is 
deemed proportional to the difference in FA concentrations outside and inside the cell and more 
importantly, it is determined by their arterial concentrations [Vik-Mo & Mjøs, 1981]. The 
cardiac source of lipids comes from either free or unesterified FAs (FFAs) or lipoprotein-bound 
or esterified FAs, the latter being especially significant [Ballard et al., 1960; Goldberg et al., 
2012].  
FA oxidation is understandably a critical process within the mitochondria of the 
myocardium. Under fasting aerobic conditions, all of 60-90% of total oxygen consumed 
contributes to FA oxidation [Vik-Mo & Mjøs, 1981]. An increase in FA oxidation in even the 
hearts of control mice can cause decreased cardiac efficiency [How et al., 2005]. Cardiac 
efficiency is determined by the oxygen requirement for a given amount of work conducted by the 
heart. Therefore, disrupted energy metabolism affects oxidative metabolism from insufficient 
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oxygen supply and thus impairing cardiac efficiency [Fillmore & Lopaschuk, 2013; Jaswal et al., 
2011]. This impaired cardiac efficiency may be a factor in the pathogenesis of heart failure 
[Fillmore & Lopaschuk, 2013]. In contrast, a decrease in lipid oxidation promotes 
cardiomyopathy and lipid accumulation in cardiomyocytes [Goldberg et al., 2012]. Some factors 
that could affect lipid oxidation include: transport of FAs into muscle cells, into the mitochondria 
and within the bloodstream, as well as their oxidation though β-oxidation and the Kreb’s cycle 
[Vik-Mo & Mjøs, 1981].  
Furthermore, a chronic decrease in the heart’s ability to oxidize FAs has been shown to 
contribute to heart failure since this fuel source reflects a crucial ATP generating pathway in the 
adult heart [Bishop & Altschuld, 1970; Taegtmeyer & Overturf, 1988; Allard et al., 1994; 
Christe & Rogers; 1994; Massie et al., 1995; Sambandam et al., 2002; Huss & Kelly, 2005].  
FAs remaining unoxidized especially by β-oxidation can be diverted towards diacylglycerol, 
triacylglycerol, ceramide and other toxic lipid productions [Lowell & Shulman, 2005; Roden, 
2005; Lopaschuk & Folmes, 2007; Lopaschuk et al., 2010]. It has been shown that decreased β-
oxidation in the heart despite elevated FA availability is associated with intramyocardial lipid 
accumulation  [Young et al., 2002]. This may stimulate a disproportionate activity between β-
oxidation and the Kreb’s cycle or even β-oxidation inhibition in favor of increased glucose 
oxidation, possibly resulting in incomplete FA oxidation and an overproduction of ROS [Saddik 
et al., 1993; Koves et al., 2005; Muoio & Koves, 2007]. 
All mitochondrial pathways are critical for the heart to ensure the acquirement of enough 
ATP without being exposed to dangerous amounts of circulating FAs nor ROS. These pathways 
need to respond to the continuous flux in energy demand and substrate availability 
proportionately and efficiently, considering the heart has a limited substrate storage capacity 
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[Huss & Kelly, 2005].  Carbohydrate and FA metabolism are considered regulators of one 
another otherwise known as the Randle cycle meaning, pyruvate dehydrogenase a key enzyme in 
carbohydrate metabolism can be inhibited by FA oxidation end products, acetyl-CoA and NADH 
[Koonen et al., 2005; Jaswal et al., 2011]. In the failing heart, there is an up-regulation in 
glycolysis while oxidative metabolism within the mitochondria is decreased [Jaswal et al., 2011]. 
Substrate availability also influences myocardial oxygen consumption (MVO2) in that FA 
utilization can in fact increase MVO2 since their oxidation has a greater oxygen requirement than
that of carbohydrates [Vik-Mo & Mjøs, 1981]. Greater FA availability than what the heart is 
normally exposed to may have negative implications for the heart muscle. In fact, a vicious cycle 
affiliated with the myocardial ischemic process may ensue when elevated free FA are left to 
circulate in the plasma, suggesting their destructive involvement in said cycle [Vik-Mo & Mjøs, 
1981].  
Cardiac metabolism can shift without delay from lipid to carbohydrate metabolism in 
order to produce necessary ATP when the heart is exposed to great demands and ischemic 
conditions, a phenomenon that can be prevented by decreasing FA oxidation through alleviating 
the oxygen requirement [Goodwin et al., 1998; Lopaschuk et al., 2010]. Uncoupling proteins 
(UCPs) cause mitochondria to shift from producing ATP to produce heat and in heart failure for 
instance, elevated levels of FFA in the plasma may activate these UCPs leading to inefficient 
OXPHOS [Vettor et al., 2002; Murray et al., 2004; Murray et al., 2008]. Atherosclerosis a risk 
factor of CVD also predisposes the development of heart failure [McGovern et al., 1996; Rosen 
et al., 2007]. In the failing heart, oxygen and ATP are utilized at a faster rate than they can be 
replenished and this becomes increasingly so [Ingwall & Weiss, 2004].  There is also an 
uncoupling of electron transport among the ETS and ATP production (uncoupled oxidative 
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phosphorylation) and wasteful energy generation yet the amount of oxygen available does not 
meet the need for energy. A decline in mitochondrial oxidative capacity as seen in the failing 
heart, may be an adaptive mechanism to compensate for shifts in cardiac mitochondrial 
physiology [Huss & Kelly, 2005]. A relationship exists among the imbalanced mitochondrial 
supply and demand along with an up-regulation of the genes responsible for fat metabolism in 
the pathogenesis of heart failure [Ingwall & Weiss, 2004].  
Therefore, gene expression is likely responsible for the shift in metabolic and energy 
metabolism in failing and normal hearts [Huss & Kelly, 2005].  PPARγ coactivator-1 (PGC-1), 
specifically PGC-1α and PGC-1β, may play a role in regulating cardiac mitochondrial substrate 
and energy metabolism (bioenergetics) respectively, as they perform similar roles in other tissues 
with great oxidative capacity [Huss & Kelly, 2005]. PGC-1α can actually be induced to increase 
mitochondrial respiratory coupling and FA oxidation by up-regulating the respective enzymes, as 
found in cultures containing cardiomyocytes while the nuclear receptor PPARα assists in this 
regulatory transcriptional cascade [Lehman et al., 2000; Huss et al., 2004; Huss &Kelly, 2005]. 
PPARα likely responds to physiological stimuli affecting FA delivery while estrogen-related 
receptors (ERRs), another type of nuclear receptor, may stimulate OXPHOS and help direct 
signaling of transcription within the PGC1-α network [Huss et al., 2004; Huss & Kelly, 2005]. 
Physiological cues from varying stimuli that affect the body influence gene expression and these 
receptors to help maintain a dynamic balance in cardiac metabolism which, favors glucose 
oxidation in the fetal heart and FA oxidation in the adult heart, as seen in Figure 2 [Huss & 
Kelly, 2005].  Although, there is an obvious preference of fuel type this favored balance is not 
fixed. A shift from the primary utilization of one energy substrate or the other depends on the 
sources of stimuli. 
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Figure 3: Shifts in energy substrate utilization affects cardiac metabolism. 
[Huss & Kelly, 2005]
On the right hand side we see the substrate shift favoring glucose that occurs in fetal and 
diseased hearts, such as in ischemic conditions. On the left hand side we see this shift favoring 
lipid substrates in cases of uncontrolled diabetes or provided with an exercise stimulus and 
generally in the heart when fatty acids are available 
.
The heart is a highly oxidative muscle of the body. Any disruption in mitochondrial 
function can stimulate disturbances in carbohydrate and lipid metabolism and more importantly 
cause disturbed cardiac function. Heart failure therefore, is thought to be an end result linked to 
the combination of mitochondrial derived oxidative stress and decreased OXPHOS [Ong & 
Hausenloy, 2010]. Gradual and progressive dysfunction in mitochondrial respiration is 
implicated in the basis of heart failure no matter the cause [Huss &Kelly, 2005]. Furthermore, 
the failing heart exhibits disturbed activity of the ETS complexes, regulation of the Kreb’s cycle 
as well as the supply and proper functioning of NADH [Sheeran & Pepe, 2006]. This is 
significant seeing as how heart failure despite technological advances remains a main cause of 
death and disability in the developed world [Sheeran & Pepe, 2006].  
J
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Rationale, objectives and hypotheses 
Cardiovascular disease is a growing international health concern and so are its associated 
risk factors such as dyslipidemia and hypercholesterolemia. These elements lead to oxidative 
stress whereby the mitochondria are impaired as seen in hepatic and skeletal muscle tissue in 
humans, rat and ApoE-/- murine models. The mitochondria are an important research target in 
regards to cardiovascular health because of their role in generating cellular energy, by means of 
oxidative phosphorylation, a process that is affected by impaired uptake of cholesterol and lipids 
from the blood (i.e. ApoE deficiency). The altered role of mitochondria may be potentially 
implicated in the pathophysiology of heart failure [Sheeran & Pepe, 2006]. The ApoE-/- murine 
model has been studied extensively and findings using this model can be highly applicable to 
public health. However, the effects of elevated cholesterol and lipid levels on the function of the 
mitochondria in the heart, specifically in cardiomyocytes, and whether this alters oxygen 
consumption in these cells has yet to be investigated.  
Despite the possible protective effect of estrogen on cardiomyocytes, CVD is still highly 
prevalent among females and not solely males, the sex in which this disease is primarily studied. 
There are sex differences in the development and implications of CVD as well [Wang et al., 
2011]. Furthermore, there are important sex differences in lipid profiles, which may contribute to 
underlying pathological mechanisms in CVD and other conditions. Using a female mouse model, 
we will examine how the heart muscle is still affected by an altered lipid profile despite their sex. 
One study by Sothern et al. showed that levels of cholesterol, especially LDL, and triglycerides 
are significantly different in obese girls and obese boys before and after weight loss [Sothern et 
al., 2000].  Differences in plasma lipid metabolism and female biased genes may account for 
these findings and therefore warrants further examination [Zhang et al., 2011]. Thus, it is just as 
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necessary to investigate implications of impaired cholesterol and other lipid clearance from the 
plasma resulting from ApoE deficiency, on cardiac physiology and function in the female sex. 
Clinically, this would lead to a better understanding of the interaction of a pro-atherosclerotic 
environment and cardiac mitochondrial roles and its potential implication in heart failure. This is 
especially importantly as CVD including heart failure are becoming more and more prevalent 
among the female sex especially, in the post-menopause state when there is a significant 
decrease in their cardioprotective effect [Wang et al., 2011], in which case the knowledge 
regarding the previously mentioned relationship would prove significantly useful. 
I investigated how an altered lipid profile, one that is favorable for the development of 
atherosclerosis and maintained in an ApoE knockout mouse, modifies energy metabolism 
otherwise known as the bioenergetics, in cardiomyocytes. Lesions can begin in the vasculature of 
this model as early as 3 weeks old making it an efficient model to use. The protocol can be easily 
replicated and applied to future studies, while the instruments used are valid and have been 
frequently used in numerous other studies [Gnaiger, 2012a]. The implication of the 
mitochondrial respiratory complexes was investigated using an established protocol that permits 
the analysis of its oxidative capacity as well as mitochondrial coupling. The results from using 
said protocol had determined whether disturbed energy metabolism was present.  
The primary objective of this study was to examine the effects of impaired clearance of 
cholesterol and lipids (i.e. elevated in the blood circulation), on promoting shifts in cardiac 
mitochondrial oxidative capacity. More specifically, I had quantified cardiac mitochondrial 
oxygen consumption of both a 2-month and an 8-month-old group using an ApoE-/- murine 
model and compared these values to age-matched controls. I then assessed whether or not the 
coupling of oxidation and phosphorylation was affected, as it is another indicator of altered 
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functioning in the respiratory capacity of mitochondria of these same groups. In addition, I 
determined the implications of ApoE deficiency on substrate and energy metabolism to evaluate 
if either of these had been disturbed in the experimental groups compared to controls. So the 
effects of a high lipid-environment over 2 different periods of time had been studied and whether 
aging had contributed any consequences in said environment. Finally, it was of interest to see
how the effects seen so far with high lipid exposure in the blood stream due to Apoe-/-, were 
amplified by saturating these lipid levels through supplementation of high amounts of fat through 
the diet. 
Hypotheses 
It was hypothesized that the mitochondria from ApoE-/- cardiomyocytes will exhibit an 
altered oxidative capacity resulting from shifts in their lipid profile compared to 2-month-old 
controls. We expected to see increased oxygen consumption in the ApoE deficient groups as 
compared to controls because of a probable increase in FA oxidation. It was also hypothesized 
that there would be an initial increase in the coupling of oxidation and phosphorylation in the 
groups lacking ApoE and not in the control groups. This was thought to likely be a compensation 
that would remain or increase with prolonged lipid exposure in the blood stream available to the 
heart in the 8 month-old experimental group compared to 2-month and 8-month-old control 
groups. Furthermore, we expected to see a shift in substrate metabolism and altered energy 
metabolism in the ApoE-/- groups as compared to controls, both in the young and older age 
groups. Finally, we expected to see these same effects only further amplified when the high lipid 
exposure was saturated with additional high amounts of lipids given through the diet. 
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Background: Apolipoprotein E (ApoE) is necessary for normal lipid metabolism. Deficiency of this 
protein hinders plasma clearance of both triglycerides and cholesterol. Lipids are, shunted through 
alternate metabolic pathways, thus resulting in abnormal mitochondrial function. Given the oxygen 
consumption required for normal heart function, the mitochondria are of particular importance and 
the preservation of their optimal function is critical.
Methods: Using high-resolution respirometry (HRR) and immunoblotting to quantify mitochondrial 
oxidative phosphorylation (OXPHOS) capacity in permeabilised cardiomyocytes, the goal of this 
study was to investigate the effects of ApoE deficiency on energy metabolism in the hearts of young 
mice.
Results: Our results demonstrate a reduced basal respiration (ADP restricted) in the ApoE-/- mice. 
This is furthermore translated to an increased efficiency of the mitochondria, as expressed by a 
higher respiratory control ratio in ApoE-/- mice.
Conclusions: This indicates that early stages of ApoE deficiency positively affects oxidation and 
phosphorylation coupling within cardiac mitochondria. Our findings provide important information 
regarding the early phases of preferential lipid metabolism in cardiomyocytes and can help 
explain the benefits of short term high fat intake for prevention of development and progression of 
heart failure.  
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Selected abbreviations
ACR - acceptor control ratio
ApoE - apolipoprotein E 
ApoE-/- - apolipoprotein E deficient 
ADP - adenosine diphosphate
ATP - adenosine triphosphate
CVD - cardiovascular disease 
ETS - electron transport system 
FADH2 - flavin adenine dinucleotide
FA - fatty acid 
GM3/GMS3 - glutamate, malate state 3 / 
glutamate, malate, succinate state 3
LDL - low-density lipoproteins  
NADH - nicotinamide adenine dinucleotide
OXPHOS - oxidative phosphorylation
RCR - respiratory control ratio 
ROS - reactive oxygen species 
ROX - residual oxygen consumption 
TRL - triglyceride-rich lipoproteins 
VDAC - voltage-dependent anion channel
VLDL - very low-density lipoproteins 
INTRODUCTION
Cardiovascular disease (CVD) is a leading public 
health concern as it lies at the root of serious ill-
ness, disability and death.Central to this condition 
is chronic inflammation whereby oxidised lipopro-
teins are deposited onto blood vessel walls [1]. Li-
poproteins are soluble molecules that enable lipid 
transport in the plasma. Of these, Apolipoprotein E 
(ApoE) is an important component in the structure 
of low-density lipoproteins (LDL) and very low-den-
sity lipoproteins (VLDL) [2]. 
It also participates in the uptake of triglyceride-
rich lipoproteins (TRL) by the liver and has, as 
such, an ability to suppress the development 
of atherosclerosis [3-4].The genetically engi-
neered ApoE deficient (ApoE-/-) mouse, estab-
lished 20 years ago and still commonly used, 
spontaneously develops elevated cholesterol 
levels similar to what is seen in humans [5-6]. 
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Hypercholesterolemia, a significant risk factor for CVD, contributes to 
high levels of oxidative stress in the vascular environment, resulting in 
endothelial dysfunction and atherogenesis [7-8]. Accumulation of oxida-
tive stress causes altered metabolism, elevated reactive oxygen species 
(ROS) production and subsequent mitochondrial damage over time. 
These factors induce pro-inflammatory pathways and other key steps in 
the pathogenesis of CVD [7]. Furthermore, the development of a fatty 
acid (FA) pool due to ApoE deficiency creates a lipotoxic state whereby 
oxidative stress is enhanced in the mitochondria, possibly inducing 
apoptosis of both adipose and nonadipose cells, as seen in various ex-
perimental models and species [9-11]. Under certain conditions, mito-
chondria are significant sources of ROS and will, when damaged (i.e. by 
long-term FA accumulation,) exhibit decreased oxidative based energy 
and thus less fuel for cells [12]. This is of fundamental importance since 
the mitochondrion is the organelle in which energy (ATP) production 
and cellular respiration occur [13-14].
Considering the maintenance of ATP drives all cellular processes, this 
process is particularly crucial for a high-level workload organ such as 
the heart due to its high-energy demands [15-19]. The capacity of the 
mitochondria relies heavily on substrate availability, specifically lipids 
and carbohydrates. Their contribution to energy metabolism is based 
on the utilisation of substrates through β-oxidation and the Kreb’s cycle. 
β-oxidation produces acetyl-CoA from FAs that enter the Kreb’s cycle, 
generating electrons that are subsequently transported to the electron 
transport system (ETS) by NADH and FADH2 in order to maximise ATP 
production [20]. The Kreb’s cycle is the main common aerobic metabolic 
pathway involving carbohydrates, lipids and proteins [21]. Acetyl-CoA 
oxidation by this cycle is responsible for two thirds of the sum of ATP 
production and oxygen consumption [22]. 
While both glucose and FAs are oxidised in the mitochondria and thus 
contribute to ATP production in the cardiomyocytes, the latter is the 
preferred substrate (generating 70% of total ATP) [23-25]. For this reason, 
the uptake of FA from the plasma is critical for cardiac viability [23-27]. 
Lipids have also been found to be necessary for the maintenance and 
re-initiation involved with the pure beating of heart cells, thus further 
emphasising their importance [28]. 
Since the heart has limited substrate storage capacity, the uptake of nu-
trients needs to be finely balanced as the underlying pathways have to 
respond both proportionately and efficiently to continuous flux in en-
ergy demand and substrate availability [19]. Under normal conditions the 
mitochondria maintains a fine equilibrium between glucose and FAs, 
however, during physiological stress, the mitochondria shifts towards 
an increased carbohydrate metabolism. This adds stress to the heart and 
shunts the lipids into non-oxidative pathways creating more ROS than 
energy [29]. The same detrimental phenomenon occurs when there is a 
reduced oxygen supply as a result of the occlusion of the coronary ves-
sels, a major cause of cardiovascular distress [30].
As CVD is a growing international health concern, more focus is placed 
on its associated risk factors, such as dyslipidemia and hypercholesterol-
emia. These elements lead to oxidative stress whereby the mitochondria 
are impaired, as seen in hepatic and skeletal muscle tissue in humans, 
rat and ApoE-/- murine models. The mitochondria are an important re-
search target in regards to cardiovascular health because of their role 
in generating cellular energy, by means of oxidative phosphorylation, 
a process affected by uptake of cholesterol and lipids from the plasma. 
The subsequently altered role of mitochondria may potentially be impli-
cated in the pathophysiology of heart failure [31].
MITOCHONDRIAL ADAPTATIONS IN YOUNG APOE -/- MICE.
The ApoE-/- murine model has been studied extensively and findings 
using this model can be highly applicable to public health; however, 
the effect of ApoE deficiency on the function of the mitochondria in the 
heart and whether this alters oxygen consumption in these cells has yet 
to be investigated. 
This study examined how a shortage of ApoE affects the cardiac mi-
tochondrial oxidative capacity. We quantified cardiac mitochondrial 
oxygen consumption in a 2-month old ApoE-/-murine model in com-
parison to age-matched controls. The results determined whether dis-
turbed energy metabolism was present by investigation of the oxidative 
capacity of the mitochondrial respiratory complexes. We hypothesised 
that the mitochondria from the ApoE-/-cardiac tissue would experience 





Two month old female, age-matched, C57Bl/6 (Control) and ApoE-/- 
(Experimental) mice were obtained from Charles River Breeding Farms 
(St Constant, Quebec, Canada) and Jackson Laboratories (Bar Harbor, 
Maine, USA) respectively. The mice were housed as breeding pairs in a 
thermo-neutral environment (22ºC), on a 12:12 h photoperiod, and were 
provided standard dry laboratory mouse chow and water ad libitum. 
The animals used in this study were weaned at 21 days and left to ma-
ture under socialising conditions until 2 months of age. All procedures 
were approved by the Animal Ethics Committee of Concordia University 
(protocol ID: 2013BERG) and were conducted in accordance with guide-
lines of the Canadian Council on Animal Care. 
The mice were not sex-matched, as all efforts were made to reduce all 
parameters to a minimum. There are a number of recognized differences 
between the sexes in terms of tissue organisation, biochemistry as well 
as response to drugs. As the focus was on investigating the effects of a 
lack of apolipoprotein E in the heart tissue, a female to female compari-
son between the ApoE knock-out and age-matched control mice gave 
a better research design. 
Experimental protocol
The beating heart was removed immediately after euthanasia with CO2 
according to the approved animal protocol and split into two different 
portions. One portion was snap frosen in liquid nitrogen, then stored at 
-80ºC for biochemical analysis; the other part (the apex) was placed in 
an ice cold relaxing buffer (BIOPS) and used immediately to measure 
mitochondrial respiration. The BIOPS contains(in mM): CaK2EGTA 2.77, 
K2EGTA 7.23, Na2ATP 5.77, MgCl2·6H2O 6.56, Taurine 20, Na2Phospho-
creatine 15, Imidazole 20 mM, Dithiothreitol 0.5, MES 50, pH 7.1. 
Snap freezing reduces the chance of water present in the sample form-
ing ice crystals during the freezing process, and thus better maintain the 
integrity of the sample. In the case of tissue, snap freezing slows the ac-
tion of proteases and nucleases which inhibit degradation of molecules 
and proteins. The snap frozen hearts can be considered to have an un-
spoiled tissue integrity very similar to the one used in our Oxygraph ex-
periments.  
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Preparation of permeabilised cardiac fibres
The apex was removed and the left ventricle dissected for prepara-
tion of permeabilised myofibres. This was done by gentle dissection 
during which the fiber bundles were separated using sharp forceps. 
The fibres were then incubated in 3 ml BIOPS buffer containing 50 
μg/ml saponin for 30 minutesand subsequently washed in ice-
cold buffer (MiR05) for 2 x 10 min. MiR05 contains (mM): EGTA 0.5, 
MgCl2·6H2O 3.0, K-lactonionate 60, Taurine 20, KH2PO4 10, HEPES 
20, Sucrose 110, BSA 1g/l, pH 7.1.
Mitochondrial respiratory measurements
Measurements of oxygen consumption were performed in MiR05 
at 37ºC using a polarographic oxygen sensor (Oxygraph-2k, Oro-
boros Instruments, Innsbruck, Austria). Approximately 2.0 to 2.5 
mg of muscle tissue (wet weight) was place in either chamber in 
a cross-sectional design. O2 flux was resolved by DatLaband all 
experiments were carried out in hyperoxygenated levels to avoid 
O2 diffusion limitations. A sequential substrate addition protocol 
was used to allow functional dissection of the electron transport 
system:state 2 respiration (absence of adenylates) was assessed by 
addition of malate (2 mM) and octanoylcarnitine (1.5 mM), by add-
ing ADP (5 mM) we could reach state 3 respiration for complex I. 
This was followed by addition of glutamate (10 mM) and succinate 
(10 mM) achieving maximal coupled state 3 respiration with paral-
lel electron input to complex I and II. 
Oligomycin(2 μg/ml) was then added to block complex V and 
thereafterantimycin A (2.5 μM) to inhibit complex III. Finally ascor-
bate (2 mM) and TMPD (500 μM) were added to evaluate Complex 
IV respiration. The acceptor control ratio (ACR) was calculated by 
dividing the respirationfollowing ADP addition by the values after 
malate titration. The respiratory control ratio (RCR) was evaluated 
by dividing the respirations of succinate by those of oligomycin for 
each of the samples while mitochondrial leak was drawn from the 
difference between oligomycin and antimycin.
Protein Extraction, Immunoblotting, and Immunofluorescence
Cell lysates were extracted in lysis buffer containing 250 mMNaCl, 
50 mM HEPES (pH 7.5) 10% glycerol, 1% triton X-100, 1.5 mM MgCl2, 
1 mM EGTA, 10 mM Na4P2O7, 1 mMNaF, 800 μM Na3VO4 and cen-
trifuged at 12,000 × g for 10 min. Supernatant was collected and 
the lysates were separated on a 12.5% SDS-PAGE and transferred 
to a nitrocellulose membrane (0.45 μm, 162-0115, Bio-Rad) using 
10 mM sodium tetraborate buffer. The membranes were blocked in 
5% BSA in TBS-T buffer (10 mm Tris-HCl, pH 7.5, 150 mm NaCl, 0.05% 
Tween 20) for 1 h at room temperature followed by overnight in-
cubation at 4°C with primary antibodies: voltage-dependent anion 
channel or VDAC, (1:3000, MSA03 MitoSciences), total OXPHOS (oxi-
dative phosphorylation) rodent antibody cocktail (1:4000, MS604 
MitoSciences) and beta-tubulin (1:5000, ab6064 Abcam). The blots 
were washed, incubated with horseradish peroxidase-conjugated 
secondary antibodies (anti-mouse, ab6728; anti-rabbit, ab6721; 
Abcam) and visualised with a chemiluminescence system (Immun-
Star Chemiluminescent; 1705070; Bio-Rad). The bands were anal-
ysed using the Image J software. 
Statistics
Summarised data are presented as means ± standard error of mean 
(SEM) in all figures. Statistical comparisons were done using a two-
tailed Student’s t-test. For all statistical evaluations, p <0.05 was 
considered significant. 
Figure 1:  No difference in mitochondrial density was detected using 
immunoblotting with the primary antibody of the voltage dependent 
anion channel (VDAC),(100 ± 6.4 vs. 107.7 ± 10.1, n = 8 control vs. 
ApoE-/-), n = 8 control vs. ApoE-/-)
RESULTS
Mitochondrial density
There was no difference (100 ± 6.4 vs. 107.7 ± 10.1) in relative mi-
tochondrial density as showed by the expression of voltage depen-
dent anion channel (VDAC) (Figure 1) when comparing control and 
ApoE-/- mice (n = 8). No changes were detected in protein expres-
sion of Complex I to Complex V when normalised with the loading 
control β-tubulin (Figure 2) using the same number of animals. 
Figure 2:  Immunoblotting of Complex I to Complex V using the 
total OXPHOS rodent antibody cocktail from MitoSciences (MS604) 
together with beta-tubulin from Abcam (ab6064) as loading control. 
No relative changes were detected when running the samples from 
control and ApoE-/- hearts (n = 8) in parallel.
Protein expression of complex I-V
Relative expression of VDAC
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Mitochondrial respiration
To establish oxidative capacities of mitochondria in the cardiac 
muscles in situ as well as control of the respiratory activity by the 
principal regulator, ADP, we studied the oxygen consumption rates 
of saponin-permeabilised fibres. As seen in Figure 3A, the hearts 
from the ApoE-/- mice showed a significantly decreased (20.6 ± 
1.4 and 11.0 ± 1.0pmol/s/mg, respectively, p< 0.001)mitochondrial 
oxidative phosphorylation (OXPHOS) capacity with the Complex 
I linked substrate malate(basal, ADP-restricted). Residual oxygen 
consumption (ROX) was similar in both groups (data not shown). 
There was a non-significant trend showing a potential increase 
in OXPHOS capacity with Complex II substrates (106.1 ± 9.5 and 
130.4 ± 14.4pmol/s/mg, p = 0.18) while the maximal, ADP stimulat-
edrespiration was similar in both groups(180.0 ± 16.5 and 217.2 ± 
35.3 pmol/s/mg). No difference was found in Complex IV OXPHOS 
capacity between the hearts from control and ApoE-/- mice (data 
not shown). 
Figure 3:  A) Hearts from the ApoE-/- mice showed a significantly 
(20.6 ± 1.4 and 11.0 ± 1.0 pmol/s/mg, respectively, p< 0.001) lower 
OXPHOS capacity with Complex I linked substrates. There was a 
non-significant trend (106.1 ± 9.5 and 130.4 ± 14.4 pmol/s/mg, 
p = 0.18) showing increase in OXPHOS capacity with Complex II 
substrates while the maximal respiration was similar in both groups 
(180.0 ± 16.5 and 217.2 ± 35.3 pmol/s/mg). 
B) There was an increase in acceptor control ratio (ACR) when 
comparing the control animals with the ApoE-/-(5.1 ± 0.33 and 
11.9 ± 0.84 pmol/s/mg, respectively, p < 0.001). n = 8.  
Figure 3B shows the acceptor control ratio (ACR, maximal, ADP 
stimulated respiration divided by basal, ADP restricted respiration), 
a ratio representing the degree of coupling between oxidation and 
phosphorylation. 
This parameter was significantly higher in ApoE-/- mice than in 
control tissue (5.1±0.3 and11.9 ± 0.8, respectively, p< 0.001).Mi-
tochondrial leak estimated as antimycin A flux rates subtracted 
from oligomycin flux rates indicated no change between the two 
mouse groups (data not shown, control 58.1 ± 4.7 and ApoE-/- 51.9 
± 6.0). No difference was seen in substrate control ratio for succi-
nate (GM3/GMS3) from the control hearts compared to the hearts 
from the ApoE-/- mice (Figure 4A). Lipid OXPHOS capacity shown in 
Figure 4B was significantly higher in hearts from control mice com-
pared to ApoE-/- (0.38 ± 0.03 and 0.28 ± 0.01, respectively, p < 0.01). 
The respiratory control ratio (RCR) was significantly higher in the 
ApoE-/- mice (2.3 ± 0.1 and 3.0 ± 0.3, p< 0.05) indicating that the 
mitochondria have a high capacity for substrate oxidation and ATP 
turnover and a low proton leak as there was no difference in mito-
chondrial density.
Figure 4:  A) No difference was detected in substrate control ratio 
(0.67 ± 0.05 and 0.63 ± 0.03 pmol/s/mg, control vs. ApoE-/-) 
B) Lipid coupling control ratio showed significant reduction in the 
ApoE-/- mice (0.38 ± 0.03 and 0.28 ± 0.01 pmol/s/mg, p < 0.01). 
Data are means ± SE. n = 8
Mitochondrial respiration
Substrate control ratios
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The increased oxygen uptake, however, is not specifically for the 
generation of ATP since it may also be play a role in fatty acid esteri-
fication andreactive oxygen species production[34-35]. Since high 
plasma lipid levels are usually associated with cellular dysfunction 
due to toxicity, it would be logical to suppose that the ApoE-/- state 
would have a negative effect on the mitochondria, with subsequent 
cardiac damage. Additionally, in prolonged obesity, where there 
is an elevation of FA, it has been shown that there is a decrease 
in the myocardial energy transduction efficiency to contractile 
work [36-37]. 
These alterations are similar to observations made in experimental 
animal models of obesity and may be responsible for the impair-
ments in cardiac contractility often seen in obese persons. Our re-
sults are consistent with findings that demonstrated that myocardi-
al FA metabolism increases before ventricular contractile function 
dysfunction[38]. In mitochondrial measurements from obese pa-
tients, the RCR was significantly enhanced, which is consistent with 
our ApoE-/- findings. RCR value analysis is very important as it re-
lates the two most important states of mitochondrial respiration(3 
and 4), and has thus become one of the most accepted parameters 
to describe the mitochondrial coupling [39]. The higher RCR values 
in the ApoE-/- hearts indicate a better coupled mitochondria, while 
the RCR valuesin the control animals indicate a degree of uncou-
pling between oxidativephosphorylation and ETC [40].
Studies in rodents suggest that, in the absence of obesity, the re-
placement of refined carbohydrates in the diet with fat can attenu-
ate or prevent the development and progression of heart failure. 
These findingssuggest the novel concept that a diet high infat and 
low in carbohydrate prevents the development and progression of 
cardiac dysfunction compared to low fat/high carbohydrate diets 
[41-42]. The idea of replacing dietary carbohydrate with fat to pre-
vent heart failure may seem counterintuitive, however, it is largely 
in line with current thinking regarding dietary fat and prevention of 
CVD[43-44]. The ingestion of a high fat diet leads to elevated concen-
trations of plasma lipids which is what we see in the ApoE-/- mice. 
The increased respiration in the ApoE deficient animals could thus 
be indicative of a similar mechanism.  
In addition, our data suggests that the heart is an important sink 
for plasma FAs, thus preventing excessive and directly harmful de-
livery of FAs to other tissues, such as in the vasculature, where shifts 
towards this metabolic source has detrimental effects. The heart, 
like the liver, is uniquely capable of disposing of FAs because of its 
high energy requirements and its ability to package and secrete 
fatty acids as VLDL [45]. Nonetheless, prolonged excessive FA deliv-
ery to the heart, as in the liver, could lead to intracellular lipid ac-
cumulation and lipotoxicity and/or oxidative stress. Furthermore, 
a chronic decrease in the heart’s ability to oxidise FAs has been 
shown to contribute to heart failure since this fuel source reflects a 
crucial ATP generating pathway in the adult heart [19, 46-51]. FAs re-
maining unoxidised, especially by β-oxidation, can be diverted to-
wards diacylglycerol, triacylglycerol, ceramide and other toxic lipids 
[38, 52-54]. It has been shown that decreased β-oxidation in the heart 
despite elevated FA availability is associated with intramyocardial 
lipid accumulation [55]. This may stimulate a disproportionate activ-
ity between β-oxidation and the Kreb’s cycle or even β-oxidation 
inhibition in favour of increased glucose oxidation, possibly result-
ing in incomplete FA oxidation [56-58].
DISCUSSION
  
The major finding of our study is that the animals with ApoE-/-have 
a reduced basal mitochondrial respiration and increased respira-
tory control ratio as a result of an accelerated lipid substrate oxida-
tion. The increase in oxidative capacity found in this study is associ-
ated with a significant increase in the coupling between oxidation 
and phosphorylation in the ApoE-/- mice as suggested by the 
higher ACR values [32]. This indicates that the cardiac tissue in the 
ApoE-/- animal has a higheroxidation:phosphorylation ratio. Since 
basal respiration is affected by both the degree of transmembrane 
proton leak and the total number of mitochondria, which was un-
changed in our study, the low Complex I stimulated/ADP restricted 
respiration in the ApoE-/- mice is most likely due to a low degree of 
transmembrane proton leak.The fact that there was no difference in 
ADP stimulated respiration (Complex II) between control and ApoE-
/-,despite there being a lower Complex I respiration, supports the 
notion that the ApoE-/- animals must have an enhanced coupling 
between oxidation and phosphorylation. Given that a high plasma 
concentration of FA has been previously associated with a concur-
rent alteration in membrane phospholipid composition, these bio-
chemical changes may explain the reduction in the leak across the 
inner mitochondrial membrane [33].
Due to a lack of ApoE, there is a subsequent increase in serum fatty 
acid levels and a subsequent shift in substrate metabolism that fa-
vors a greater dependency on FA as a primary energy source. This 
reliance on FA results in an increased myocardial respiration (as 
seen by an increase in RCR) because more oxygen is required to 
generate ATP from fatty acids than glucose. 
Figure 5:  The respiratory control ratio in the ApoE-/- mice was 
up regulated indicating a more efficient oxidation of substrates 
(2.3 ± 0.11 and 3.0 ± 0.29pmol/s/mg, p < 0.05, n = 8)
Respiratory control ratio
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Cardiovascular disease (CVD) in the elderly is a 
leading public health concern as it relates to serious 
illness, disability and death [1, 2]. Central to the 
pathogenesis is an altered lipid profile whereby 
oxidized lipoproteins deposit onto the vasculature 
subsequently resulting in chronic inflammation [3]. 
























following increased fatty acid oxidation and oxygen 
consumption suggestive of uncoupling or altered 
energy metabolism in cardiac mitochondria when 
exposed to high lipid content [4]. Apolipoprotein E 
(ApoE) is vital for its structural role in low-density 
lipoproteins (LDL) and very low-density 
lipoproteins (VLDL) [5]. ApoE also enables hepatic 
Effects of age-related cardiac redox dysregulation in 
apolipoprotein E deficient mice. 
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uptake of triglyceride-rich lipoproteins (TRL) and 
may help regulate inflammatory and antioxidant 
pathways [6, 7]. ApoE deficiency is consequently 
involved in the pathophysiology of atherosclerosis 
and dyslipidemia [8].  
Fatty acid (FA) accumulation driven by ApoE 
deficiency induces a lipotoxic state in mitochondria 
due to oxidative stress [9-11]. Furthermore, a 
chronic decline in the heart’s ability to oxidize FAs 
has been shown to contribute to heart failure [12-
18]. FAs remaining deoxidized can be diverted 
towards diacylglycerol, triacylglycerol, ceramide 
and other toxic lipid productions [19-22]. Reduced 
FA oxidation may provoke disproportionate activity 
between β-oxidation and the Kreb’s cycle or β-
oxidation inhibition in favor of increased glucose 
oxidation, subsequently resulting in incomplete FA 
oxidation and an overproduction of ROS [23-25]. 
What makes this shift troublesome is that OXPHOS 
function has been shown to decrease in aging 
mitochondria [26]. The age related defects [27] 
impede enzyme activity in the ETC, particularly in 
regards to complexes III and IV with no changes 
reported in complexes I and II [28, 29]. In addition, 
the apoptosis related to cytochrome c in both right 
and left ventricles has been found to significantly 
increase with age [30]. The aging process also lead 
to an altered lipid profile and impaired resistance to 
stress [31, 32]. Taken together, the mitochondria 
become even more susceptible to oxidative stress 
and ROS production [33] with aging accompanied 
by altered mitochondrial metabolism in the heart 
[28, 29, 34, 35]. Such conditions, turn the 
mitochondria into both a significant source and 
target of reactive oxygen species (ROS) and 
contributes to a reduction in ATP [36]. This is 
especially troublesome in the heart considering its 
high-energy demands and intense workload [37-40, 
18]. The capacity of the mitochondria relies heavily 
on substrate availability, specifically, preferred 
lipids but also carbohydrates [41-43].  
Under normal physiological conditions, the rate of 
uptake of FAs by muscle fibers is proportional to 
the difference in lipid concentrations outside and 
inside the cell [44]. Given the limited storage of 
substrates in the heart, there is a dynamic 
homeostasis between uptake, cardiac responsiveness 
to substrate availability and the flux in energy 
demands [18]. Cardiac efficiency is determined by 
the oxygen requirement for a given workload. 
Therefore, insufficient oxygen supply will affect 
oxidative phosphorylation and impair cardiac 
efficiency, which makes it a primary factor in the 
pathogenesis of heart failure [45, 46]. In contrast, a 
decrease in lipid oxidation promotes 
cardiomyopathy and lipid accumulation in 
cardiomyocytes [37]. Some factors that could affect 
lipid oxidation include: transport of FAs into muscle 
cells, into the mitochondria and within the 
bloodstream, as well as their oxidation though β-
oxidation and the Kreb’s cycle [44]. Furthermore, 
elevated FFAs, which are intrinsic uncoupling 
protein activators, lead to increased levels of 
uncoupling protein 3 (UCP3) and thus increased 
mitochondrial uncoupling [47, 48]. 
Uncoupling proteins (UCPs) normally moderate the 
proton leak across the inner mitochondrial 
membrane in order to regulate mitochondrial 
oxidant or ROS production [49]. However, they can 
also cause mitochondria to shift from ATP to heat 
production and in heart failure for instance, elevated 
levels of FFA in the plasma may activate these 
UCPs leading to inefficient OXPHOS [50, 51]. 
UCP3 in the heart has even been linked with FFA in 
the plasma of human hearts [48] and perhaps with 
decreased cardiac efficiency seen in mice [52]. 
Substrate availability also influences myocardial 
oxygen consumption (MVO2) in that FA utilization 
can in fact increase MVO2 since their oxidation has 
a greater oxygen requirement that that of 
carbohydrates [44]. Such an increase in MVO2 can 
reflect mitochondrial uncoupling of ATP production 
and oxygen consumption [53]. Despite this increase 
as seen in failing hearts to compensate for a higher 
ATP demand [54, 55], the greater FA availability 
can induce oxygen deprivation [11]. In fact, a 
vicious cycle affiliated with the myocardial 
ischemic process may ensue when elevated free FA 
are left to circulate in the plasma, suggesting their 
destructive involvement in said cycle [44].  
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The mitochondria are a crucial research target 
considering their role in aging and since their main 
function of generating cellular energy is disturbed 
by excessive uptake of lipids from the plasma [56]. 
The findings drawn from an ApoE-/- murine model 
can be highly applicable to public health and in 
further understanding ApoE’s role in CVD 
development, as well as in expanding treatment 
options for such mitochondrial related diseases. 
However, the long-term effect of ApoE deficiency 
on the function of the cardiac mitochondria and 
whether this alters their oxygen consumption 
despite the aging process remains unanswered.  
This study examined how ApoE deficiency affects 
cardiac mitochondrial oxidative capacity. We 
compared cardiac mitochondrial oxygen 
consumption and protein expression in a matured 8-
month old ApoE-/- murine model to age-matched 
controls and compared them to 2-month old control 
and ApoE-/- groups. We hypothesized that the 
mitochondria from the matured 8-month old ApoE-
/- cardiac tissue would experience decreased 
respiratory function and energy metabolism as 
compared to controls resulting from a high lipid 
environment or exposure rather than from a 
prominent age-related effects.  
 
Materials and Methods 
Animal Care 
We used 2-month and 8-month-old female C57Bl/6 
(Control) and ApoE-/- (Experimental) mice 
obtained from Charles River Breeding Farms (St 
Constant, Quebec, Canada) and Jackson 
Laboratories (Bar Harbor, Maine, USA) 
respectively. The mice were weaned at 21-25 days, 
left to mature under socializing conditions in a 
thermo-neutral environment (22ºC) on a 12:12 h 
photoperiod and provided with standard dry 
laboratory mouse chow and water ad libitum. All 
procedures were approved by the Animal Ethics 
Committee of Concordia University (protocol ID: 
#30000259). The protocols were conducted in 
accordance with guidelines of the Canadian Council 
on Animal Care.  
Experimental protocol 
The heart was removed following euthanasia with 
CO2 and immediately split in two separate portions. 
One part was snap frozen in liquid nitrogen, and 
later stored at -80ºC for future biochemical analysis 
while the apex was placed in an ice cold relaxing 
buffer (BIOPS). It was used instantly to measure 
mitochondrial respiration. The BIOPS buffer was 
comprised of the following (in mM): CaK2EGTA 
2.77, K2EGTA 7.23, Na2ATP 5.77, MgCl2·6H2O 
6.56, Taurine 20, Na2Phosphocreatine 15, Imidazole 
20, Dithiothreitol 0.5, MES 50, pH 7.1 
Preparation of permeabilized cardiac fibers 
Through gentle dissection the fiber bundles from the 
apex were separated using sharp forceps. The fibers 
were then incubated on ice in 3 ml BIOPS buffer 
containing 50 µg/ml saponin for 30 minutes and 
subsequently washed in ice-cold buffer (MiR05) for 
2 x 10 min. MiR05 contains (mM): EGTA 0.5, 
MgCl2·6H2O 3.0, K-lactonionate 60, Taurine 20, 
KH2PO4 10, HEPES 20, Sucrose 110, BSA 1g/l, pH 
7.1. 
 
Mitochondrial respiratory measurements 
Measurements of oxygen consumption were 
performed in MiR05 at 37ºC using a polarographic 
oxygen sensor (Oxygraph-2k, Oroboros 
Instruments, Innsbruck, Austria). Approximately 2.0 
to 2.5 mg of muscle tissue (wet weight) was 
analyzed in a cross-sectional design. O2 flux was 
resolved by DatLab and all experiments were 
carried out in hyperoxygenated levels to avoid O2 
diffusion limitations. Using a sequential substrate 
addition protocol we were able to functionally 
dissection the electron transport system: state 2 
respiration (absence of adenylates) was assessed by 
addition of malate (2 mM) and octanoyl carnitine 
(1.5 mM), by adding ADP (5 mM) we could reach 
state 3 respiration for complex I. This was followed 
by addition of glutamate (10 mM) and succinate (10 
mM) achieving maximal coupled state 3 respiration 
with parallel electron input to complex I and II. 
Oligomycin (2 μg/ml) was then added to block 
complex V and thereafter antimycin A (2.5 μM) to 
inhibit complex III. Finally ascorbate (2 mM) and 
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TMPD (500 μM) were added to analyze Complex 
IV respiration. The acceptor control ratio (ACR) 
was calculated by dividing the respirations of ADP 
by those of malate for each sample. The respiratory 
control ratio (RCR) was evaluated by dividing the 
respirations of succinate by those of oligomycin for 
each of the samples. The mitochondrial leak was 
drawn from the difference between oligomycin and 
antimycin  
A respirations of each sample. The lipid coupling 
control ratio (L/P) was calculated by dividing 
octanoyl carnitine respirations by those of glutamate 
per sample. Lastly, the substrate control ratio (SCR) 
was evaluated by diving glutamate respirations by 
those of succinate for each of the samples.  
 
Mitochondrial Uncoupling 
There were 6 different protocols, some of which 
were variations of one another, used to test for 
uncoupling as we wanted to be ensure that the 
results obtained would not be from a potential 
uncoupling effect. The first protocol began with the 
addition of oligomycin (2 μg/ml) followed by 
succinate (10 mM), then FCCP step titrations (1 
μl/step) and finally antimycin A (2.5 μM). The 
second protocol was the same as the first except 
GDP (10mM) was added in between the addition of 
succinate and FCCP. The third protocol consisted of 
the sequential addition of succinate (10 mM), ADP 
(5 mM) and then glutamate (10 mM) and malate (2 
mM) simultaneously. The fourth protocol included 
the addition of malate (2 mM), octanoyl carnitine 
(1.5 mM), ADP (5 mM), glutamate (10 mM), 
oligomycin (2 μg/ml) and then finally multiple 
additions of GDP (10mM). The fifth protocol began 
with the addition of malate (2 mM) then octanoyl 
carnitine (1.5 mM), glutamate (10 mM), oligomycin 
(2 μg/ml) and again multiple additions of GDP 
(10mM). The sixth an final protocol consisted of 
adding malate (2 mM) then octanoyl carnitine (1.5 
mM), oligomycin (2 μg/ml) and then multiple 
additions of GDP (10mM). Uncoupling protein 2 
and 3 (UCP2 and UCP3)-mediated uncoupling 
could hence be investigated through the titrations of 
oligomycin, GDP and antimycin A. 
 
Protein Extraction, Immunoblotting, and 
Immunofluorescence 
Cell lysates were isolated in lysis buffer containing 
250 mM NaCl, 50 mM HEPES (pH 7.5) 10% 
glycerol, 1% triton X-100, 1.5 mM MgCl2, 1 mM 
EGTA, 10 mM Na4P2O7, 1 mM NaF, 800 µM 
Na3VO4 and centrifuged at 12,000 × g for 10 min. 
The supernatant was collected and separated on a 
12.5% SDS-PAGE and transferred to a 
nitrocellulose membrane (0.45 μm, 162-0115, Bio-
Rad) by using a 10 mM sodium tetraborate buffer. 
The membranes were blocked in 5% BSA in TBS-T 
buffer (10 mm Tris-HCl, pH 7.5, 150 mm NaCl, 
0.05% Tween 20) for a duration of 1 h at room 
temperature. Afterward, the membranes were left to 
incubate overnight at 4°C with primary antibodies: 
total OXPHOS rodent antibody cocktail (1:4000, 
MS604 MitoSciences) and beta-tubulin (1:5000, 
ab6064 Abcam). The blots were washed, incubated 
with horseradish peroxidase-conjugated secondary 
antibodies (anti-mouse, ab6728; anti-rabbit, ab6721; 
Abcam) and visualized with a chemiluminescence 
system (Immun-Star Chemiluminescent; 1705070; 
Bio-Rad). The bands were analyzed using the Image 
J softwareto analyze protein expression of 




Summarized data are presented as means ± standard 
error of mean (SEM) in all figures. Statistical 
comparisons were done using a two-tailed Student’s 
t-test. For all statistical evaluations, p < 0.05 was 
considered significant. The number of samples is 
represented by n. 
Results 
Relative Expression of Complexes I-V 
Immunoblotting revealed a statistically significant 
increase in CI between the young control group and 
the older control group (100 ± 20.2 and 346.8 ± 
50.3, respectively, p<0.03) as well as in the older 
ApoE-/- group (100.0 ± 20.2 and 209.4 ±34.6, 
respectively, p<0.05), normalized to the young 
control group. These trends can be seen in Figure 1. 
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The other complexes (CII-CV) showed no 
statistically significant difference in expression. 
There was also a significant decrease in protein 
expression between the older control and older 
ApoE-/- group (346.8 ± 50.3, respectively, p<0.05). 
These results indicate both the presence of an aging 
and experimentally induced effect. Please note that 
the values for the control expression has been set to 
100% in order to display relative changes. This does 
not mean however, that the mitochondrial 
complexes have identical expression. 
 
Mitochondrial respiration  
By examining oxygen consumption rates of 
saponin-permeabilized fibres we determined 
oxidative capacities of mitochondria in the cardiac 
muscles in situ along with control of the respiratory 
activity by ADP, the main regulator. The O2 flux 
showed an increased response in both the older 
control and ApoE-/- as compared to controls (data 
not shown). Residual oxygen consumption (ROX) 
was similar in both groups (data not shown).  
 
 
Figure 1: Immunoblotting of Complex I to Complex V 
using total OXPHOS rodent antibody cocktail from 
MitoSciences (MS604). There is a significant increase 
between CI of young control and old control (100 ± 20.2 
and 346.8 ± 50.3, respectively, p<0.03) as well as older 
ApoE-/- (100.0 ± 20.2 and 209.4 ±34.6, respectively, 
p<0.05) as represented by *. There is also a significant 
decrease in CI between the old control and the old ApoE 
group (346.8 ± 50.3, respectively, p<0.05) represented by 
#. The other complexes show no significant increases. 
The data show both an aging and experimental effect. 
 
Mitochondrial leak, estimated as antimycin A flux 
rates substracted from oligomycin flux rates, 
indicated a significant increase in the 8-month-old 
ApoE-/- group compared to the younger one as seen 
in Figure 2 (92.6 ± 15.5 vs 46.4 ± 4.72pmol/s/mg, 
respectively, p<0. 03). Figure 4 shows no 
significant increase between these two groups in 
terms of substrate control ratio for succinate 
(GM3/GMS3) (0.56 ± 0.04 and 0.59 ± 0.03, 
respectively), neither for the respiratory control 
ratio (RCR, state 3 over state 4 respiration so 
succinate divided by oligomycin respiration) as seen 
in Figure 7 (2.6 ± 0.2 and 2.9 ± 0.4, respectively).  
 
Figure 2: Mitochodnrial leak assessed by the difference 
between oligomycin and anitmycin A average rates of 
respiration. The data reflect a significantly increased 
mitochondrial leak in the older ApoE-/- group compared 
to controls (92.6 ± 15.5 vs 46.4 ± 4.72pmol/s/mg, 
respectively, p<0.03, n=11). 
 
Acceptor control ratio shown in Figure 6 (ACR, 
maximal, ADP stimulated respiration divided by 
basal, ADP restricted respiration in other words 
ADP divided by malate respiration), a ratio 
representing the degree of coupling between 
oxidation and phosphorylation showed no 
significant increases (11.2 ± 0.9 and 13.0 ± 2.23, 
respectively). There was also no significant 
difference in the lipid coupling control ratio (L/P) 
(0.25 ± 0.02 and 0.25 ± 0.02) between these two 
same groups illustrated in Figure 5. Lipid OXPHOS 
capacity or the lipid coupling control ratio (L/P) 
shows the absence of a significant difference 
between these same two groups. However, there 
was a significant difference in substrate utilization 
that being significantly higher in the 8-month 
ApoE-/- group for the majority of the substrates as 
seen in Figure 3. Data show a significant increase in 
the utilization of malate (7.63 ± 1.55 and 12.9 ± 
1.11, p<0.02), octanoyl carnitine (26.3 ± 5.0 and 
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and 141.6pmol/s/mg ± 14.6, p<0.02), glutamate 
(104.4 ± 17.0 and 171.4pmol/s/mg ± 17.07, p<0.02), 
succinate (182.8 ± 27.2 and 289.5pmol/s/mg ± 22.9, 
p<0.01) by comparing the 2-month ApoE-/- to the 
8-month-old ApoE-/- group (n=11). Although 
oligomycin utilization also significantly increased 
(64.9 ± 6.5 and 110.7pmol/s/mg ± 15.9, p<0.03) 
there was no significant change in antimycin A or in 
ascorbate and TMPD (18.5 ± 3.9 and 
18.1pmol/s/mg  ± 2.2; 242.0  ± 40.8 and 
207.6pmol/s/mg ± 37.4, respectively) between the 
young and older ApoE-/- groups. 
 
 
Figure 3: Substrate utilization by the mitochondria of 
permeabilized cardiac myofibers assessed through high-
resolution respirometry (n=11). Data show a significant 
increase in the utilization of malate (7.63 ± 1.55 and 12.9 
± 1.11 , p<0.02), octanoyl carnitine (26.3 ± 5.0 and 
42.0pmol/s/mg ± 3.3, p<0.02), ADP (86.8 ± 15.5 and 
141.6pmol/s/mg ± 14.6, p<0.02), glutamate (104.4 ± 17.0 
and 171.4pmol/s/mg ± 17.07, p<0.02), succinate (182.8 ± 
27.2 and 289.5pmol/s/mg ± 22.9, p<0.01) and 
oligomycin (64.9 ± 6.5 and 110.7pmol/s/mg ± 15.9, 
p<0.03). Antimycin A and ascorbate+TMPD utilization 
were not significant (18.5 ± 3.9 and 18.1pmol/s/mg  ± 
2.2; 242.0  ± 40.8 and 207.6 pmol/s/mg ± 37.4, 




There was no significant uncoupling found using 
any of the 6 uncoupling protocols (data not shown). 
The mitochondrial leak observed in this project 




There was an aging effect observed between our 2-
month control and 8-month control groups. Despite 
this aging effect we can still report significant 
results as previously described.  
 
Figure 4: Substrate control ratio (SCR) representing how 
the mitochondria handle different substrates expressed by 
dividing glutamate by succinate average rates of 
respiration. Data show a non-significant increase in this 
ratio from young to the older ApoE-/- group (0.56 ± 0.04 
and 0.59 ± 0.03, respectively, n=11). 
 
 
Figure 5: Lipid coupling control ratio (L/P) reflecting the 
efficiency to utilize lipids yet under similar respiratory 
levels, obatined by dividing octanoyl carnitine by 
glutamate average rates of respiration. The data show no 
significant increase in the L/P from the young to the 
older ApoE-/- group (0.25 ± 0.02 and 0.25 ± 0.02, 
respectively, n=11).  
 
Figure 6: The acceptor control ratio (ACR) assesses the 
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dividing ADP by malate average rates of respiration. The 
data illustrate a non-significant decrease in the ACR of 
the older ApoE-/- group compared to the younger group  
(11.2 ± 0.9 and 13.0 ± 2.23, respectively, n=11). 
 
 
Figure 7: The respiratory control ratio (RCR) represents 
state 3 respiration over state 4 respiration obtained by 
diving succinate by oligomycin average rates of 
respiration. The data demonstrate a non-significant 
increase in the between the young and older ApoE-/- 
groups (2.6 ± 0.2 and 2.9 ± 0.4, respectively, n=11). 
 
Discussion  
The main finding of this study is that the 8 month 
control and ApoE deficient group both experienced 
altered cellular metabolism and mitochondrial 
protein expression. There may be a shift in lipid 
levels as it is known that chow fed control mice as 
used in this study have total plasma cholesterol 
(PC), low-density lipoprotein (LDL), high-density 
lipoprotein (HDL) and triglycerides (TG) levels of 
around 60, 10, 50 and 65mg/dL respectively [57-
60]. In contrast, the ApoE-/- model fed normal show 
an increase in PC (8-fold), LDL (14-fold), and TG 
1.7-fold) with a shift from HDL to very-low-density 
lipoprotein (VLDL), where most of the PC 
lipoprotein fractions become rather atherogenic [57-
64]. This shift between HDL and VLDL becomes 
especially prominent with a further increase in these 
values when these deficient animals are 
supplemented with a high fatt diet [57, 62, 63, 65]. 
Other studies have shown that at 8 months of age 
ApoE-/- mice experience close to 90% occlusion 
when fed a high fat diet [66], a diet-induced 
occlusion comparable to humans [67]. It is likely 
that our results are translatable to a male 8-month 
old ApoE-/- model considering that it has been 
shown that as the animals age, the discrepancies 
between the sexes becomes negligible [68].  
As the heart ages there is known to be an excessive 
generation of oxidative stress thus implicating the 
mitochondria in the pathogenesis of cardiovascular 
disease [69, 70] since this stress is detrimental to the 
heart with a potential to increase the amount of ROS 
produced. Hence, the paralleled need in research 
and for clinicians to better understand the effects of 
aging on cardiac mitochondrial metabolism and 
bioenergetics. Therefore, this model promotes the 
study of the interactions between lipid metabolism, 
cardiac mitochondria and aging. Typically, the 
cellular effects attributed to aging in turn, promote 
cardiac aging [71] forming a destructive cycle. 
Aging induces increased ROS, reduced OXPHOS 
and mitochondrial dysfunction [72] yet we observed 
increased mitochondrial respiratory efficiency, 
which may seem counterintuitive. However, in 
recent studies mitochondria have proven vital in 
longevity, stimulating mitochondrial fitness and 
healthy aging despite age-related cellular changes, 
for their ability to alter expression of mitochondrial 
ribosomal protein [73] and their upregulation of 
cytoprotective activities [72]. 
Although there was an aging effect between our 2-
month control and 8-month control groups we 
nevertheless saw statistically significant differences 
between our 2-month ApoE-/- and 8-month ApoE-/- 
groups, between young and older control groups as 
well as the older ApoE-/- group. Finally, there was 
also significance between the older control and 
older ApoE-/- groups. Furthermore, we found no 
significant age-related declines in complex III and 
IV as reported in other studies [34, 28, 29, 74-77]. 
Meanwhile, complex II only slightly increased as 
predicted [76-79, 74], seeing as how the proteins in 
this complex are not encoded for by mitochondrial 
DNA (mtDNA) [80]. Therefore, previously reported 
results coincide with our findings. Complex I was 
the most affected in this study in both aged groups, 
which is also expected considering 7 of the 13 
mtDNA encoded proteins of the respiratory 
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Based on the L/P, there was no impairment in lipid 
oxidation. Voltage-dependent anion channel 
(VDAC) would have to be performed as well as 
incorporating cytochrome c to see to determine if 
mitochondrial density was altered and to further 
comprehend the basis for the mitochondrial leak 
effect. One study found ROS generation within the 
mitochondria during metabolism and was 
compensated for by means of a proton leak [82]. 
Uncoupling protein 1 (UCP1) was not found to 
jeopardize OXPHOS or the production of ATP [82], 
both of which were not compromised in our study. 
It is this same UCP1 that contributes to nearly 80% 
of the proton leak in skeletal muscle mitochondria. 
Similarly, our observed increase in proton leak 
cannot be associated with reductions in ATP 
synthesis, in RCR nor with age-related diminished 
state 3 respiration, as described in a number of other 
studies [26]. Energy demands and ROS are no doubt 
increasing as the cardiac mitochondria metabolize 
the elevated lipid levels in our study, so perhaps 
they too generated a proton leak as compensation. 
VDAC and cytochrome c would also be a useful 
features as there is a reported decrease in the overall 
quantity of cardiomyocytes, along with a significant 
increase in cytochrome c with aging [30]. In 
addition, VDAC would help in indicating whether 
any disruptions in equilibrium between 
mitochondrial biogenesis and mitophagy had 
occurred with aging and the high lipid availability 
[83]. 
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The recent rise in obesity has been associated with a 
number of adverse health effects such as heart disease, 
certain types of cancer, type-2 diabetes mellitus, and 
respiratory complications [1]. In efforts to reduce 
associated health risks, overweight and obese patients 
have been advised to maintain a healthy BMI. One of 
the most efficient means of weight loss is through 
dieting, more specifically a low-carbohydrate. This diet 
has gained much popularity with the American public 
[2], and advocates claim it ‘burns more fat’ and leads 



































effects [3]. Macronutrient composition is altered in a 
low-carbohydrate diet, drastically affecting the cellular 
metabolism. Although the same energy sources are 
utilized, majority of the energy is now derived from 
fatty acids and ketones due to the extreme reduction of 
carbohydrate. This shifts metabolism from a 
‘glucocentric’ source to an ‘adipocentric’ energy 
source [4]. In low-carbohydrate high-fat (LCHF) 
metabolism, 70% of caloric requirements come from 
fatty acids via dietary fat or lipolysis, 20% come from 
ketone bodies acetoacetate and β-hydroxybutyrate, and 
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Summary: Low-carbohydrate diets have been growing in popularity in America for decades, proving to be one of the 
most popular and efficient methods of weight loss. Despite the superficial health benefits this type of diet may 
contribute in the case insulin resistance, hypertension, and lipid control for example, its implications on mitochondrial 
oxidative capacity and respiration have yet to be evaluated. The goal of this study was to evaluate the safety of low-
carbohydrate high-fat (LCHF) diets by determining whether they foster an environment altering mitochondrial 
functioning. Male Apolipoprotein E-deficient mice were randomly assigned to either a control diet or low-
carbohydrate high-protein diet for 6 weeks. Heart tissue was used for immunoblotting, and high-resolution 
respirometry (HRR) to quantify mitochondrial complexes and measure oxidative phosphorylation (OXPHOS) 
capacity. Our results indicate increased expression of all five mitochondrial complexes in the LCHF group compared 
to the control. Furthermore, HRR revealed increased efficiency of substrate utilization implying improved 
mitochondrial respiration. These findings correlate well with the understanding that cardiomyocytes prefer lipid as a 
fuel source, and the shift in metabolism caused by a LCHF diet provides such a favourable environment. 
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10% from glucose via gluconeogenesis or 
glycogenolysis [5]. Low-carbohydrate diets have been 
studied extensively in the past decades regarding 
weight loss, lipid markers, insulin sensitivity, 
hypertension, and endothelial dysfunction [6-11]. 
However, no study has addressed a possible link with 
LCHF diets and heart failure due to cardiac 
mitochondrial dysfunction. 
 
Despite a general decrease in the number of deaths 
from cardiovascular disease (CVD) in the United 
States, congestive heart failure (CHF) remains as 
prevalent today as it was two decades ago [12]. 
Although very broadly defined, CHF can be best 
described as a multifactorial syndrome that renders the 
myocardium unable to pump blood efficiently to 
sustain demand [13]. Oxidative stress is now 
understood to be a key factor in heart failure, and a 
main reason for oxidative stress is the imbalance and 
negative impact of reactive oxygen species (ROS) 
produced by the mitochondria [14-18]. In recent years, 
studies have linked characteristics of heart failure to 
defective mitochondrial energetics and abnormal 
substrate metabolism [19- 21]. There is significant 
evidence showing mitochondrial dysfunction not only 
in cardiomyocytes, but also skeletal muscle of heart 
failure patients [22]. Aside from mitochondrial 
dysfunction, other problems that may contribute to the 
noticeable energetic defects are the number of 
mitochondria, substrate of choice, or oxidative capacity 
[23]. These facts imply that preserving cardiac 
mitochondrial functioning can become a future 
therapeutic aim for CHF [24-26]. 
 
Mitochondria are potentially significant sources of 
ROS especially when damaged (i.e. by long-term FA 
accumulation,) where they exhibit decreased oxidative 
based energy and thus less fuel for cells [27]. This is a 
central concern since the mitochondrion is the 
organelle in which energy (ATP) production and 
cellular respiration occur [28, 29]. Considering the 
maintenance of ATP drives all cellular processes, this 
process is imperative for a high-level workload organ 
such as the heart due to its high-energy demands [25, 
30-33]. The capacity of the mitochondria relies heavily 
on substrate availability, notably lipids and 
carbohydrates. These substrates contribute to energy 
metabolism depending on their utilization through β-
oxidation and the Kreb’s cycle. β-oxidation produces 
acetyl-CoA from FAs that enters the Kreb’s cycle, 
generating electrons that are successively transported to 
the electron transport system (ETS) by NADH and 
FADH2 to amplify ATP production [34]. The Kreb’s 
cycle is the focal common aerobic metabolic pathway 
for carbohydrates, lipids and proteins [35]. Acetyl-CoA 
oxidation by this cycle is responsible for two thirds of 
the sum of ATP production and oxygen consumption 
[36].  
 
Despite glucose and FAs both being oxidized in the 
mitochondria to ATP production in the 
cardiomyocytes, the latter is the preferred substrate 
(generating 70% of total ATP) [37-39]. Therefore, the 
uptake of FA from the plasma is vital for cardiac 
viability [21, 37- 40]. Furthermore, lipids have also 
been deemed necessary for the maintenance and re-
initiation involved with the pure beating of heart cells, 
further highlighting their significance [41]. The heart 
has limited substrate storage capacity, thus the uptake 
of nutrients needs to be finely balanced since the 
underlying pathways have to respond both 
appropriately and competently to the continuous flux in 
energy demand and substrate availability [25]. Under 
normal conditions the mitochondria maintain a fine 
equilibrium between glucose and FAs, however, during 
physiological stress, the mitochondria shifts towards an 
increased carbohydrate metabolism. This shift adds 
stress to the heart and shunts the lipids into non-
oxidative pathways creating more ROS than energy 
[42]. The activity of respiratory complex I in the 
mitochondria is especially prone to the effects of 
oxidative damage [43]. The same detrimental 
phenomenon occurs when there is a reduced oxygen 
supply as a result of the occlusion of the coronary 
vessels, a major cause of cardiovascular distress [44].  
 
The mitochondria are an important health research 
target considering their role in generating cellular 
energy, by means of oxidative phosphorylation, a 
process affected by uptake of cholesterol and lipids 
from the plasma. The subsequently altered role of 
mitochondria may potentially be implicated in the 
To be submitted to Journal of Lipid Research  April 2015 
39 
pathophysiology of heart failure [45] and overall 
cardiovascular health. The apolipoprotein E deficient 
(ApoE-/-) murine model is a well-established model as 
it allows for the investigation of atherosclerosis due to 
its susceptibility to develop lesions rapidly, and 
similarly to humans  [46-48]. ApoE is a 34 kDa 
glycoprotein made in the liver and brain, responsible 
for lipoprotein metabolism [48]. It helps to clear 
circulating cholesterol by mediating the binding of 
ApoE-containing lipoproteins and LDL receptors [49- 
52]. 
 
This study examined whether ApoE-/- mice exhibit 
altered cardiac mitochondrial oxidative capacity when 
exposed to a LCHF environment. We quantified 
cardiac mitochondrial consumption in a 6-week old 
ApoE-/- murine model in comparison to age-matched 
controls. The results determined if alterations in energy 
metabolism had occurred by examining the oxidative 
capacity of the mitochondrial respiratory complexes. 
We hypothesized that the mitochondria from the ApoE-
/- cardiac tissue would experience increased respiratory 





Apolipoprotein E knockout (ApoE-/-) mice were 
obtained from Jackson Laboratories (Bar Harbor, 
Maine, USA) and used for breeding. The resulting 
litters were weaned and separated based on sex at 21-
28 days. Only the tissue from male mice was used for 
the purpose of this study. The males were housed 
individually in a thermo-neutral environment (22ºC), 
on a 12:12 h photoperiod, and randomly assigned to 
either a control diet (CON) or a low-carbohydrate high-
fat (LCHF) diet for 6 weeks. Both groups of mice had 
access to water and their respective diets ad libitum. 
All procedures were approved by the Animal Ethics 
Committee of Concordia University (protocol ID: 
#30000259) and were conducted in accordance with 
guidelines of the Canadian Council on Animal Care.  
 
Diet Specifications 
Both CON and LCHF animal diets were iso-caloric. 
Table 1 displays the diet specifications in terms of 
percentage of caloric intake from fat, carbohydrates 
(CHO) and protein. The CON diet, 5075 Charles River 
Autoclavable Rodent Diet, reflects a healthy, standard 
macronutrient distribution. Whereas, the LCHF diet, 
obtained from Harlan Laboratories (TD.04524) 
simulates an Atkin’s diet used for weight loss and 
contains 43% from fat, 11% CHO, and 46% protein. 
The LCHF diet is a modification of TD.88137 (Harlan 
Laboratories), used for studies on atherosclerosis.  
 
Experimental protocol 
The beating heart was removed immediately after 
euthanasia with CO2 according to the approved animal 
protocol and split into two different portions. One 
portion was snap frozen in liquid nitrogen, and stored 
at -80ºC for biochemical analysis; the other portion (the 
apex) was placed in an ice cold relaxing buffer 
(BIOPS) and used immediately to measure 
mitochondrial respiration. The BIOPS contains (in 
mM): CaK2EGTA 2.77, K2EGTA 7.23, Na2ATP 5.77, 
MgCl2·6H2O 6.56, Taurine 20, Na2Phosphocreatine 15, 
Imidazole 20 mM, Dithiothreitol 0.5, MES 50, pH 7.1 
 
Preparation of permeabilized cardiac fibers 
The apex was dissected for preparation of 
permeabilized myofibers. This was done by gentle 
dissection during which the fiber bundles were 
separated using sharp forceps. The fibers were then 
incubated in 3 ml BIOPS buffer containing 50 µg/ml 
saponin for 30 minutes and subsequently washed in 
ice-cold buffer (MiR05) for 2 x 10 min. MiR05 
contains (mM): EGTA 0.5, MgCl2·6H2O 3.0, K-
lactonionate 60, Taurine 20, KH2PO4 10, HEPES 20, 
Sucrose 110, BSA 1g/l, pH 7.1. 
 
Mitochondrial respiratory measurements
Measurements of oxygen consumption were performed 
in MiR05 at 37ºC using a polarographic oxygen sensor 
(Oxygraph-2k, Oroboros Instruments, Innsbruck, 
Austria). Approximately 2.0 to 2.5 mg of muscle tissue 
(wet weight) was place in either chamber in a cross-
sectional design. O2 flux was resolved by DatLab and 
all experiments were carried out in hyperoxygenated 
levels to avoid O2 diffusion limitations. A sequential 
substrate addition protocol was used to allow 
functional dissection of the electron transport system: 
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state 2 respiration (absence of adenylates) was assessed 
by addition of malate (2 mM) and octanoyl carnitine 
(1.5 mM), by adding ADP (5 mM) we could reach state 
3 respiration for complex I. This was followed by 
addition of glutamate (10 mM) and succinate (10 mM) 
achieving maximal coupled state 3 respiration with 
parallel electron input to complex I and II. Oligomycin 
(2 μg/ml) was then added to block complex V and 
thereafter antimycin A (2.5 μM) to inhibit complex III. 
Finally ascorbate (2 mM) and TMPD (500 μM) were 
added to evaluate Complex IV respiration.  These 
mitochondrial respiratory measurements were recorded 
for both the control group and the experimental group 
fed the LCHP diet. 
 
Mitochondrial Uncoupling 
There were 6 different protocols, some of which were 
variations of one another, used to test for the presence 
of uncoupling as we wanted to ensure that the results 
obtained would not be from a potential uncoupling 
effect. A portion of the apex tissue mentioned 
previously was also studied using high-resolution 
respirometry (Oxygraph-2k, Oroboros Instruments, 
Innsbruck, Austria) to test for uncoupling, running 
simultaneously along side the mitochondrial respiratory 
experiments. The first protocol began with the addition 
of oligomycin (2 μg/ml) followed by succinate (10 
mM), then FCCP step titrations (1 μl/step) and finally 
antimycin A (2.5 μM). The second protocol was the 
same as the first except GDP (10mM) was added in 
between the addition of succinate and FCCP. 
Therefore, uncoupling protein 1 (UCP1)-mediated 
uncoupling could be studied through the titrations of 
oligomycin, GDP and antimycin A. The third protocol 
consisted of the sequential addition of succinate (10 
mM), ADP (5 mM) and then glutamate (10 mM) and 
malate (2 mM) simultaneously. The fourth protocol 
included the addition of malate (2 mM), octanoyl 
carnitine (1.5 mM), ADP (5 mM), glutamate (10 mM), 
oligomycin (2 μg/ml) and then finally multiple 
additions of GDP (10mM). The fifth protocol began 
with the addition of malate (2 mM) then octanoyl 
carnitine (1.5 mM), glutamate (10 mM), oligomycin (2 
μg/ml) and again multiple additions of GDP (10mM). 
The sixth an final protocol consisted of adding malate 
(2 mM) then octanoyl carnitine (1.5 mM), oligomycin 
(2 μg/ml) and then multiple additions of GDP (10mM). 
 
Protein Extraction, Immunoblotting, and 
Immunofluorescence 
Tissue from the cross-section excised from right above 
the apex was pulverized/homogenized using liquid 
nitrogen with ~150μl lysis buffer containing (in mM) 
250 NaCl, 50 HEPES (pH 7.5), 10% glycerol, 1% 
triton X-100, 1.5 MgCl2 1 EGTA, 10 Na4P2O7  NaF, 
800 μM Na3VO4. After 1 h on ice the cell slurry was 
centrifuged at 13,000 rpm for 10 min, and the 
supernatant was collected. 10μl of lysate was mixed 
with 2μl DTT and 2μl sample buffer and loaded on a 
12.5% acrylamide-SDS gel followed by a transfer onto 
a 0.45μm nitrocellulose membrane (162-0115 Bio-Rad) 
in 10mM sodium tetraborate buffer. Ponceau staining 
was done as loading control before the membranes 
were blocked in 3% bovine serum albumin (BSA) in 
0.1% Tween in Tris-buffered saline  (TBS) (10 mm 
Tris-HCl, pH 7.5, 150 mm NaCl) for 1 hour at room 
temperature, followed by overnight incubation at 4°C 
with primary antibody, total OXPHOS rodent antibody 
cocktail (1:2000, MS604 MitoSciences).  The 
membranes were washed, and incubated with 
secondary antibody (1:15000, anti-mouse, ab6728 
Abcam). Membranes were exposed with ECL 
chemiluminescence (Immun-Star Chemiluminescent; 
1705070; Bio-Rad) and developed bands were 
analyzed with Image J Software. 
 
Statistical Analysis 
Summarized data are presented as means ± standard 
error of the mean (SEM) for immunoblotting, and 
standard estimate.  Statistical comparisons were done 
using a two-tailed Student’s t-test. n represents the 
sample number. For all statistical evaluations, In the 




Relative Expression of Complexes I-V 
Immunoblotting revealed an increase in all five 
complexes in the LCHF diet, normalized to the CON. 
These trends can be seen in Figure 1 however, only 
CIV showed a statistically significant difference in 
To be submitted to Journal of Lipid Research  April 2015 
41 
expression (CON: 100% ±5.7, LCHP: 122% ±4.8, p< 
0.05 n= 6). Therefore, the only significant change in 
protein expression was in CIV when running samples 










Mitochondrial respiration  
We examined oxygen consumption rates of saponin-
permeabilized fibres to determine oxidative capacities 
of mitochondria in the cardiac muscles in situ along 
with control of the respiratory activity by ADP, the 
principal regulator. Mitochondrial leak, estimated as 
antimycin A flux rates subtracted from oligomycin flux 
rates, indicated a significant increase in the LCHF 
group as compared to the control group as seen in 
Figure 3 (52.4 ± 16.1 and 102.2 ± 12.1pmol/s/mg, 
respectively, p<0.03). There was also a significant 
difference between these two groups in terms of 
substrate control ratio for succinate (GM3/GMS3) 
(0.62 ± 0.08 and 0.44 ± 0.02, respectively, p<0.05) as 
illustrated in Figure 4. Neither the respiratory control 
ratio (RCR, state 3 over state 4 respiration so succinate 
divided by oligomycin respiration) (2.2 ± 0.8 and 3.0 ± 
0.6 ) or the acceptor control ratio (ACR, maximal, ADP 
stimulated respiration divided by basal, ADP restricted 
respiration in other words ADP divided by malate 
respiration) (8.5 ± 1.4 and 12.0 ± 1.4), respectively, a 
ratio representing the degree of coupling between 
oxidation and phosphorylation showed any significant 
differences as seen in Figures 5 and 6. Therefore there 
was no indication of a likely more efficient oxidation 
of substrates, nor a significant change within the 
OXPHOS process. Lipid OXPHOS capacity shown in 
Figure 7 shows the absence of a significant difference 
in the lipid coupling control ratio (L/P) between these 
two same groups (0.33 ± 0.04 and 0.26 ± 0.03). 
However, there was a significant difference in substrate 
utilization, as seen in Figure 2. Data show a significant 
increase in the utilization of octanoyl carnitine (28.3 ± 
2.8 and 38.4pmol/s/mg ± 2.9, p<0.03), ADP (75.0 ± 5.6 
and 140.0pmol/s/mg ±25.1, p<0.03), glutamate (87.2 ± 
5.1 and 161.8pmol/s/mg ± 25.9, p<0.02), succinate 
(155.5 ± 27.0 and 362.8pmol/s/mg ± 47.9, p<0.01), 
oligomycin (74.8 ± 14.8 and 122.1pmol/s/mg ± 13.5, 
p<0.04) and ascorbate+TMPD (212.5 ± 24.8 and 
292.9pmol/s/mg ±  19.5, p<0.03) by the LCHP group 
compared to controls (n=6). Malate and antimycin A 
utilization were not significant (9.7 ± 1.2 and 
11.6pmol/s/mg  ± 1.34; 22.4  ± 4.3 and 20.0 pmol/s/mg 
± 3.5, respectively). The O2 flux showed an increased 
response in the LCHF group as the substrates were 
titrated as compared to controls (data not shown). 
Residual oxygen consumption (ROX) was similar in 

























































Figure 2: Substrate utilization by the mitochondria of 
permeabilized cardiac myofibers assessed through high-
resolution respirometry. Data show a significant increase 
in the utilization of octanoyl carnitine (28.3 ± 2.8 and 
38.4pmol/s/mg ± 2.9, p<0.03), ADP (75.0 ± 5.6 and 
140.0pmol/s/mg ±25.1, p<0.03), glutamate (87.2 ± 5.1 
and 161.8pmol/s/mg ± 25.9, p<0.02), succinate (155.5 ± 
27.0 and 362.8pmol/s/mg ± 47.9, p<0.01), oligomycin 
(74.8 ± 14.8 and 122.1pmol/s/mg ± 13.5, p<0.04)  and 
ascorbate+TMPD (212.5 ±  24.8 and 292.9pmol/s/mg ±  
19.5, p<0.03) by the LCHF group compared to controls 
(n=6). Malate and antimycin A utilization were not 
significant (9.7 ± 1.2 and 11.6pmol/s/mg  ± 1.34; 22.4  ± 
4.3 and 20.0 pmol/s/mg ± 3.5, respectively). 
Figure 1: Immunoblotting of Complex I to Complex V 
using total OXPHOS rodent antibody cocktail from 
MitoSciences (MS604). Trends show an increase in all 5 
complexes in the LCHP diet relative to the CON diet (CI 
100%± 21.4 and 132.7%± 13.1, CII 100%± 8 and 
114.8%± 8.5, CIII 100%± 13.3 and 144.9± 20.8, CIV 
100%± 5.7 and 122.1%± 5.7 p<0.02, CV 100%± 8.4 and 
188.5%± 7.3, respectively, n=6). 




































The main finding of this study is that animals assigned 
to a LCHF diet experience a drastic shift in cellular 
metabolism due to altered macronutrient distribution, 
favoring an increase in the efficiency of mitochondrial 
respiration. Taken together, the significant decrease in 
SCR and increase substrate utilization, specifically of 
ADP, indicate an increase in the efficiency of the 
mitochondria to metabolize different substrates. This 
observation was paralleled by protein expression using 

























































Figure 3:Mitochodnrial leak assessed by the difference 
between oligomycin and anitmycin a average rates of 
respiration. The data reflect a significantly increased 
mitochondrial leak in the LCHF group compared to 
controls (102.2 ± 12.1 vs 52.4 ± 16.1pmol/s/mg, 
respectively, p<0.03, n=6). 

Figure 4: Substrate control ratio (SCR) representing how 
the mitochondria handle different substrates expressed by 
dividing glutamate by succinate average rates of 
respiration. Data show a significant decrease in this ratio 
from control to the LCHF group (0.62 ± 0.08 and 0.44 ± 
0.02, respectively, p<0.05, n=6). 
Figure 5: Lipid coupling control ratio (L/P) reflecting 
the efficiency to utilize lipids yet under similar 
respiratory levels, obtained by dividing octanoyl 
carnitine by glutamate average rates of respiration. The 
data show a non-significant decrease in the L/P from the 
control to the LCHF group (0.33 ± 0.04 and 0.26 ± 0.03, 
respectively, n=6).  

Figure 6: The acceptor control ratio (ACR) assesses the 
relative quality of phosphorylation determined by 
dividing ADP by malate average rates of respiration. The 
data illustrate a non-significant increase in the ACR of 
the LCHF group compared to the control group  (12.0 ± 
1.4 and 8.5 ± 1.4, respectively, n=6). 
Figure 7: The respiratory control ratio (RCR) represents 
state 3 respiration over state 4 respiration obtained by 
diving succinate by oligomycin average rates of 
respiration. The data demonstrate a non-significant 
increase in the RCR of the control group in comparison 
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in the LCHF diet compared to the CON, with a 
significant increase in complex 4. The relatively high 
lipid content in the LCHP diet is most probably what 
impacts the mitochondria in this study rather than the 
elevated protein content, considering the two main fuel 
sources for cardiac mitochondria are carbohydrates and 
lipids. The low-carbohydrate content shifts 
mitochondrial metabolism in the heart towards its 
preferred fuel, lipids [53]. Due to the lack of ApoE in 
the CON and LCHF groups, there is a baseline increase 
in serum fatty acid levels, which is only supplemented 
with additional lipid substrate availability in the LCHF 
group due to the altered macronutrient composition. 
This may lead to an even more prominent substrate 
metabolism shift as previously mentioned, that would 
promote a greater dependency on fatty acids as the 
source of energy as seen in previous studies [54]. 
 
One possible hypothesis to explain our results would be 
that it may be in fact cytochrome c that is affected by 
the high lipid environment induced by the LCHF diet 
and not directly complex IV. The extremely basic and 
minute hemoprotein, cytochrome c, is plentiful in the 
mitochondrial intermembrane space. Its main two roles 
are transporting electrons in mitochondrial respiration 
and by being released into the cytosol from the 
mitochondria, it subsequently activates the apoptotic 
pathway [55-58]. The upregulation of complex IV may 
be a compensation for how the relatively high lipid 
content in this diet affects cytochrome c.  The second 
possible hypothesis that could contribute to better 
interpreting our results would be an upregulation in β-
oxidation responding to the elevated fatty acid 
availability. Complex I and II are less important in 
creating a proton gradient however, β-oxidation likely 
provides an extra stimulus somewhere between 
complexes I or II and complex IV promoting the extra 
surge of shuttled electrons into complex IV. 
Cytochrome c’s role would also be somewhat 
implicated in this potential explanation as well.  
 
Fatty acid metabolism has a higher oxygen cost as 
compared to carbohydrate metabolism which could 
lead to ischemic-like conditions when the mitochondria 
experience a prolonged exposure to a high lipid 
environment. Studies have shown that ischemia leads 
to a loss of cytochrome c (59). Therefore in the LCHF 
group, there may have been a change in the presence of 
cytochrome c thus in turn affecting complex IV and the 
electron leak from the cardiac mitochondria, altering 
overall mitochondrial respiration. 
 
All in all, these speculations are in accordance with our 
findings since there was an increase in substrate 
utilization yet a decrease in SCR, implying a decrease 
in complex I. ADP being significantly increased in the 
LCHF group along with the significantly increased 
expression of complex IV could translate into an 
increased electron flow somewhere in the path towards 
complex IV, a critical component in removing 
electrons from the system. This is typically evaluated 
through effects on cytochrome c. 
 
The significant increase in mitochondrial leak despite 
no presence of an uncoupling effect, nor a change in 
the degree of coupling between oxidation and 
phosphorylation, as seen with the L/P ratio, would have 
to be further evaluated for thorough understanding of 
this effect. In addition, variations in mitochondrial 
density should be assessed with expression of voltage-
dependent anion channel (VDAC) using 
immunoblotting. To further evaluate the hypothetical 
interpretations of our data, we could monitor changes 
when using cytochrome c during high-resolution 
respirometry titrations using the Oxygraph in 
supplemental experiments, to confirm whether it is 
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The aim of this thesis was to investigate whether elevated plasma lipid levels and age 
impact energetic demands of the heart and substrate metabolism. These alterations could be 
critical in affecting cardiac performance. Any important findings regarding modified 
bioenergetics of the heart holds immense promise, considering the clinical applications to the 
growing numbers of people afflicted with CVD every day. A greater understanding of the 
influence and mechanism of altered oxidative capacity of the heart is significant, since the heart 
consumes the most oxygen in the body. 
Using females was unique yet highly applicable, considering the non-sex discriminating 
pathogenesis of CVD and its comorbidities and sex differences in lipid profiles. The 
interpretation of our results will contribute to understanding the overall influence of ApoE’s 
disrupted role in lipid metabolism on cardiac mitochondrial oxidative capacity. Our findings also
further reinforce the relevance of this model even today.  
Both a short-term and prolonged exposure to a high-lipid environment proved to affect 
the mitochondria in a potentially beneficial manner, regardless of age-related effects in the latter. 
Even when the cardiac mitochondria were supplemented with additional lipids through the 
LCHF diet, saturating their plasma lipid levels, there were compensatory adaptations in 
metabolism and bioenergetics that ensued, which may prove to be advantageous. Therefore, this 
thesis will hopefully contribute to removing the stigma surrounding lipids and the belief that all 
they cause is harm. All fats however, are not created equal. There is a caveat in that processed 
fats will continue to be harmful for overall health but the appropriate types of fat abundantly 
present among other nutrient,s do promote benefits in cellular respiration and metabolism as 
shown in the cardiac mitochondria. It would thus potentially harmful to oxidative tissues such as 
49 
the heart to eliminate fats as is done in most forms of dieting. Finally, just because an over 
abundance of lipids proves to be advantageous and induces improved functioning in the heart, 
we would have to examine the effects on any of the surrounding tissues. It is likely that there is 
delicate balance in the amount of lipids that can be beneficial to both the heart and other parts of 
the body. However, this thesis would support the efficacy of lipids in protecting the 
mitochondrial function within the heart.  
If given the opportunity, it would be useful to conduct additional experiments to see if
chronic lipid exposure in even older animals would diminish the alterations observed in 
mitochondrial respiration. Probing for VDAC expression and adding cytochrome c during HRR 
or may provide a more comprehensive view of altered mitochondrial metabolism. I would like to 
use the same techniques along with mass spectrometry to see how others vital oxygen-dependent 
organs, such as the brain and liver, would be affected by cardiac mitochondrial adaptations to
high lipid levels and aging. New information can expand our knowledge of physiological 
processes in the heart, how they may become susceptible to pathogenesis or destructive pathways 
and suggest possible future research targets for prospective treatments. This thesis further 
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